Aziyo Biologics, Inc. announced it has entered into a distribution agreement with LeMaitre Vascular, Inc. Under the agreement terms, Aziyo will grant LeMaitre exclusive U.S. distribution rights for the products within its cardiovascular segment: ProxiCor PC, ProxiCor CTR, Tyke and VasCure. Aziyo's cardiovascular products are based on an extracellular matrix derived from porcine small intestine submucosa, which has been shown to modulate biologic healing response and reduce inflammation in a range of surgical applications. The products include: Proxicor PC, used for pericardial closure; ProxiCor CTR, Tykes, the only extracellular matrix cleared for neonatal and infant patch, pledget and cardiac repair; and VasCure for vascular repair.

The term of the collaboration is three years, and LeMaitre will have the exclusive option to acquire the product line following the first year or under certain other circumstances.